Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

1
Player Avatar steveaelliott (< 20) Submitted: 6/11/2007 1:08:26 PM : Outperform Start Price: $2.13 CLRT Score: +142.19

Strong in oncology field

Featured Broker Partners


Advertisement